High prevalence of gastrointestinal symptoms in patients with primary Sjögren’s syndrome cannot be attributed to pancreatic exocrine insufficiency

References

• Vitali C, Bombardieri S, Jonsson R, et al. Classification criteria for Sjögren’s syndrome: a revised version of the European criteria proposed by the American-European consensus group. Ann Rheum Dis. 2002;61(6):554–558.
   PubMed Web of Science ®Google Scholar
• Mariette X, Criswell LA. Primary Sjögren’s syndrome. N Engl J Med. 2018;378(10):931–939.
   PubMed Web of Science ®Google Scholar
• Fox RI. Sjögren's syndrome. Lancet. 2005;366(9482):321–331.
   PubMed Web of Science ®Google Scholar
• Westhoff G, Zink A. [Epidemiology of primary Sjörgren’s syndrome]. Z Rheumatol. 2010;69(1):41–49.
   PubMed Web of Science ®Google Scholar
• Löhr JM, Dominguez-Munoz E, Rosendahl J, et al. United European gastroenterology evidence-based guidelines for the diagnosis and therapy of chronic pancreatitis (HaPanEU). United European Gastroenterol J. 2017;5(2):153–199.
   PubMed Web of Science ®Google Scholar
• Capurso G, Traini M, Piciucchi M, et al. Exocrine pancreatic insufficiency: prevalence, diagnosis, and management. Clin Exp Gastroenterol. 2019;12:129–139.
   PubMed Web of Science ®Google Scholar
• Ebert EC. Gastrointestinal and hepatic manifestations of Sjogren syndrome. J Clin Gastroenterol. 2012;46(1):25–30.
   PubMed Web of Science ®Google Scholar
• Afzelius P, Fallentin EM, Larsen S, et al. Pancreatic function and morphology in Sjögren’s syndrome. Scand J Gastroenterol. 2010;45(6):752–758.
   PubMed Web of Science ®Google Scholar
• Gobelet C, Gerster JC, Rappoport G, et al. A controlled study of the exocrine pancreatic function in Sjögren’s syndrome and rheumatoid arthritis. Clin Rheumatol. 1983;2(2):139–143.
   PubMed Web of Science ®Google Scholar
• Coll J, Navarro S, Tomas R, et al. Exocrine pancreatic function in Sjögren’s syndrome. Arch Intern Med. 1989;149(4):848–852.
   PubMedGoogle Scholar
• Hradský M, Bartos V, Keller O. Pancreatic function in Sjögren’s syndrome. Gastroenterologia. 1967;108(5):252–260.
   PubMedGoogle Scholar
• Kvarnström M, Ottosson V, Nordmark B, et al. Incident cases of primary Sjögren’s syndrome during a 5-year period in Stockholm county: a descriptive study of the patients and their characteristics. Scand J Rheumatol. 2015;44(2):135–142.
   PubMed Web of Science ®Google Scholar
• Kulich KR, Madisch A, Pacini F, et al. Reliability and validity of the gastrointestinal symptom rating scale (GSRS) and quality of life in reflux and dyspepsia (QOLRAD) questionnaire in dyspepsia: a six-country study. Health Qual Life Outcomes. 2008;6:12.
   PubMed Web of Science ®Google Scholar
• Dimenäs E, Carlsson G, Glise H, et al. Relevance of norm values as part of the documentation of quality of life instruments for use in upper gastrointestinal disease. Scand J Gastroenterol Suppl. 1996;221:8–13.
   PubMedGoogle Scholar
• Dimenäs E, Glise H, Hallerbäck B, et al. Well-being and gastrointestinal symptoms among patients referred to endoscopy owing to suspected duodenal ulcer. Scand J Gastroenterol. 1995;30(11):1046–1052.
   PubMed Web of Science ®Google Scholar
• Kjellström L, Molinder H, Agréus L, et al. A randomly selected population sample undergoing colonoscopy: prevalence of the irritable bowel syndrome and the impact of selection factors. Eur J Gastroenterol Hepatol. 2014;26(3):268–275.
   PubMed Web of Science ®Google Scholar
• Schäfer SK, Weidner KJ, Hoppner J, et al. Design and validation of a German version of the GSRS-IBS - an analysis of its psychometric quality and factorial structure. BMC Gastroenterol. 2017;17(1):139.
   PubMed Web of Science ®Google Scholar
• Wiklund IK, Fullerton S, Hawkey CJ, et al. An irritable bowel syndrome-specific symptom questionnaire: DEVELOPMENT and validation. Scand J Gastroenterol. 2003;38(9):947–954.
   PubMed Web of Science ®Google Scholar
• Ljótsson B, Jones M, Talley NJ, et al. Discriminant and convergent validity of the GSRS-IBS symptom severity measure for irritable bowel syndrome: a population study. United European Gastroenterol J. 2020;8(3):284–292.
   PubMed Web of Science ®Google Scholar
• Domínguez-Muñoz JE, DH P, Lerch MM, et al. Potential for screening for pancreatic exocrine insufficiency using the fecal elastase-1 test. Dig Dis Sci. 2017;62(5):1119–1130.
   PubMed Web of Science ®Google Scholar
• van Dijk-van Aalst K, Van Den Driessche M, van Der Schoor S, et al. 13C mixed triglyceride breath test: a noninvasive method to assess lipase activity in children. J Pediatr Gastroenterol Nutr. 2001;32(5):579–585.
   PubMed Web of Science ®Google Scholar
• Keller J, Meier V, Wolfram KU, et al. Sensitivity and specificity of an abbreviated (13)C-mixed triglyceride breath test for measurement of pancreatic exocrine function. United European Gastroenterol J. 2014;2(4):288–294.
   PubMed Web of Science ®Google Scholar
• Austin PC. An introduction to propensity score methods for reducing the effects of confounding in observational studies. Multivariate Behav Res. 2011;46(3):399–424.
   PubMed Web of Science ®Google Scholar
• Fenster LF, Buchanan WW, Laster L, et al. Studies of pancreatic function in sjoegren's syndrome. Ann Intern Med. 1964;61:498–508.
   PubMed Web of Science ®Google Scholar
• Dreiling DA, Soto MJ. The pancreatic involvement in disseminated “collagen” disorders. Studies of pancreatic secretion in patients with scleroderma and sjögren’s “disease”. Am J Gastroenterol. 1976;66(6):546–553.
   PubMed Web of Science ®Google Scholar
• Tsianos EB, Vasakos S, Drosos AA, et al. The gastrointestinal involvement in primary sjögren's syndrome. Scand J Rheumatol Suppl. 1986;61:151–155.
   PubMedGoogle Scholar
• Lindström E, Lindström F, von Schenck H, et al. Pancreatic ductal morphology and function in primary sjögren's syndrome. Int J Pancreatol. 1991;8(2):141–149.
   PubMedGoogle Scholar
• Sundkvist G, Lindahl G, Koskinen P, et al. Pancreatic autoantibodies and pancreatic function in Sjögren’s syndrome. J Intern Med. 1991;229(1):61–66.
   PubMed Web of Science ®Google Scholar
• Nishimori I, Morita M, Kino J, et al. Pancreatic involvement in patients with Sjögren’s syndrome and primary biliary cirrhosis. Int J Pancreatol. 1995;17(1):47–54.
   PubMedGoogle Scholar
• Ostuni PA, Gazzetto G, Chieco-Bianchi F, et al. Pancreatic exocrine involvement in primary sjögren's syndrome. Scand J Rheumatol. 1996;25(1):47–51.
   PubMed Web of Science ®Google Scholar
• Andersson R, Löhr JM, Working Group for Chronic Pancreatitis Guidelines (Sweden). Swedish national guidelines for chronic pancreatitis. Scand J Gastroenterol. 2021;56(4):469–483.
   PubMed Web of Science ®Google Scholar
• Siegmund E, Löhr JM, Schuff-Werner P. The diagnostic validity of non-invasive pancreatic function tests-a meta-analysis. Z Gastroenterol. 2004;42(10):1117–1128.
   PubMed Web of Science ®Google Scholar
• Saluja A, Dudeja V, Dawra R, et al. Early intra-acinar events in pathogenesis of pancreatitis. Gastroenterology. 2019;156(7):1979–1993.
   PubMed Web of Science ®Google Scholar
• Ludwig H, Schernthaner G, Scherak O, et al. Antibodies to pancreatic duct cells in sjögren's syndrome and rheumatoid arthritis. Gut. 1977;18(4):311–315.
   PubMed Web of Science ®Google Scholar
• Nieminen U, Koivisto T, Kahri A, et al. Sjögren’s syndrome with chronic pancreatitis, sclerosing cholangitis, and pulmonary infiltrations. Am J Gastroenterol. 1997;92(1):139–142.
   PubMed Web of Science ®Google Scholar
• Constantopoulos SH, Tsianos EV, Moutsopoulos HM. Pulmonary and gastrointestinal manifestations of Sjögren’s syndrome. Rheum Dis Clin North Am. 1992;18(3):617–635.
   PubMed Web of Science ®Google Scholar
• Tsianos EV, Moutsopoulos HM. Sjögren's syndrome and the gut. Baillieres Clin Rheumatol. 1989;3(2):357–370.
   PubMed Web of Science ®Google Scholar
• Vivino FB. Sjogren’s syndrome: clinical aspects. Clin Immunol. 2017;182:48–54.
   PubMed Web of Science ®Google Scholar